The Global Casting and Splinting Products Market predicted to reach US$ 3,337.6 million by 2025
The global casting and splinting products market was valued at US$ 2,253.3 million in 2017 and is predicted to reach US$ 3,337.6 million by 2025, growing at a CAGR of 6.4 percent from 2017 to 2025.
Market Insights
The global casting and splinting goods market is expected to increase at a healthy rate in the next years, owing to rising musculoskeletal diseases, an aging population, and product advancements. The rise of the casting and splinting industry is aided by an increase in the number of sports and fitness activities, adventure sports-related injuries, and transit accidents. The rising frequency of age-related musculoskeletal illnesses, owing to an ever-increasing elderly population, is expected to create sales volume growth potential in this market. Furthermore, advancements in the nature of materials used in casting and splinting products, as well as improved treatment adherence and treatment outcomes, are predicted to boost the proliferation of these products.
This market is divided into two groups of casting and splinting products based on the type of product. Casting products include plaster casts, casting tapes, cast cutters, and casting tools and accessories, whereas splinting products include fiberglass splints, plaster splints, other splints, and splinting equipment and accessories. Casting products are expected to account for a bigger revenue share throughout the projection period, with cast cutters leading the market as a result of product design advancement, allowing for quick and easy cast removal.
The Asia Pacific leads the market for casting and splinting products in terms of geographical spread. The high population pool in nations like Japan, China, and India contributes significantly to Asia Pacific's supremacy in the global casting and splinting products market..This region also provides manufacturers with options to build bases in order to produce more cost-competitive products and gain a competitive advantage. Furthermore, the healthy state of the North American market is due to a big pool of senescent population in North America as a result of increased life expectancy and a well-structured reimbursement environment.
The market for casting and splinting products is fiercely competitive, with local firms posing a significant threat to industry incumbents. 3M & Company, AliMed, Bird & Cronin Inc., BSN Medical GmbH, Corflex, Inc., DeRoyal Industries, DJO Global, Orfit Industries N.V., Ossur hf, Patterson Medical Holdings Inc., Prime Medical Inc., Spencer Italia S.r.l., Stryker Corporation, and Zimmer Biomet Holdings, Inc.
Comments
Post a Comment